Related Experiment Video

Updated: May 31, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Proteolytic control of the oncoprotein transcription factor Myc

Lance R Thomas1, William P Tansey

  • 1Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA.

Advances in Cancer Research
|June 28, 2011
PubMed

Insights

The oncogene Myc, crucial for cell growth, is rapidly degraded by proteolysis. This review explores how ubiquitin-mediated proteolysis regulates Myc stability and its implications in cancer therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The c-Myc oncogene is a key transcription factor regulating cell growth and proliferation.
  • Cells possess robust mechanisms to limit Myc expression and activity, primarily through rapid protein degradation.
  • Proteolysis of Myc ensures its levels are tightly controlled and linked to cellular processes.

Purpose of the Study:

  • To review the regulation of Myc protein stability.
  • To elucidate the role of ubiquitin-mediated proteolysis in Myc destruction.
  • To discuss the dysregulation of Myc stability in cancer and potential therapeutic strategies.

Main Methods:

  • Review of existing literature on Myc proteolysis.
  • Analysis of the ubiquitin-proteasome system's role in Myc degradation.
  • Examination of ubiquitin ligases and deubiquitylating enzymes involved in Myc stability.

Main Results:

  • Myc protein is rapidly degraded via ubiquitin-mediated proteolysis shortly after synthesis.
  • Specific ubiquitin ligases and deubiquitylating enzymes play critical roles in controlling Myc stability.
  • Aberrant regulation of these processes contributes to cancer development.

Conclusions:

  • Understanding Myc proteolysis is crucial for comprehending its oncogenic potential.
  • The ubiquitin-proteasome system offers promising targets for anti-cancer therapies.
  • Targeting Myc stability could provide novel strategies for treating human malignancies.

More Related Videos

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...